Clovis Oncology, Inc. (CLVSQ) vs Dare Bioscience, Inc. (DARE)
Clovis Oncology, Inc. and Dare Bioscience, Inc. are both Biotechnology companies. Clovis Oncology, Inc. and Dare Bioscience, Inc. are of similar size ($14.5M and $14.2M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 7,817.5% against −14.8%. Clovis Oncology, Inc. has the higher net margin (−189.4% vs −804.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Clovis Oncology, Inc. leads on 10 and Dare Bioscience, Inc. on 6.
Valuation
Profitability
| Metric | CLVSQ | DARE | Biotechnology median |
|---|---|---|---|
| Gross margin | 72.21% | 58.84% | 65.16% |
| Operating margin | (155.38%) | (813.35%) | 0.00% |
| Net margin | (189.37%) | (804.33%) | 0.00% |
| Free cash flow margin | (132.19%) | (849.36%) | 0.00% |
| Return on equity | 78.31% | 165.29% | (57.72%) |
| Return on assets | (58.94%) | (62.16%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack